Nutritional Supplementation with Chlorella pyrenoidosa for Fibromyalgia Syndrome: A Double-Blind, Placebo-Controlled, Crossover Study

REFERENCES

• Wolfe F. When to diagnose fibromyalgia. Rheumatic Disease Clinics North America 1994; 20: 485–501
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe H A, Yanus M B, Bennett R M, Bombardier C, Goldenberg D L, Tugwell P, Campbell S M, Abeles M, Clark P, Fam A G, Farber S J, Fiechtner J J, Franklin C M, Gatter R A, Hamaty D, Lessard J, Lichtbroun A S, Masi A T, McCain G A, Reynolds W J, Romano T J, Russell I J, Sheon R P. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160–172
   PubMed Web of Science ®Google Scholar
• Goldenberg D L, Felson D T, Dinerman H. A randomized controlled trial of amitriptyline and Naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986; 29: 1371–1377
   PubMed Web of Science ®Google Scholar
• Russell I J, Flechter E M, Michalek J E, McBroom P C, Hester G C. Treatment of primary fibrositis/fibromyalgia syndrome with Ibuprofen and Alprazolam. A double-blind, placebo-controlled study. Arthritis Rheum 1991; 34: 552–560
   PubMed Web of Science ®Google Scholar
• Carette S, Bell M J, Reynolds W J, Haraoui B, McCain G A, Bykerk V P, Edworthy S M, Baron M, Koehler B E, Fam A G, Bellamy N, Guimont C. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. Ar thritis Rheum 1994; 37: 32–40
   PubMed Web of Science ®Google Scholar
• Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39: 1852–1859
   PubMed Web of Science ®Google Scholar
• Smith A J. The analgesic effects of selective serotonin reuptake inhibitors. J Psychopharmacol 1998; 12: 407–413
   PubMed Web of Science ®Google Scholar
• Merchant R E, Carmack C A, Wise C M. Nutritional supplementation with Chlorella pyrenoidosa for patients with fibromyalgia syndrome: A pilot study. Phytotherapy Res 2000; 14: 167–173
   PubMedGoogle Scholar
• Miyazawa Y, Murayama T, Ooya N, Wang L F, Tung Y C, Yamaguchi N. Immunomodulation by unicellular green algae [Chlorella pyrenoidosa] in tumor-bearing mice. J Ethnopharmacol 1988; 24: 135–146
   PubMed Web of Science ®Google Scholar
• Tanaka K, Koga T, Konishi F, Nakamura M, Mitsuyama M, Himeno K. Augmentation of host defense by a unicellular alga, Chlorella vulgaris to Escherichia coli infection. Infect Immun 1986; 53: 267–271
   PubMed Web of Science ®Google Scholar
• Konishi F, Tanaka K, Himeno K, Taniguchi K, Nomoto K. Antitumor effect induced by a hot water extract of Chlorella vulgaris [CE]: resistance to Meth-A tumor growth mediated by CE-induced polymorphonuclear leucocytes. Cancer Immunol Immunother 1985; 19: 73–78
   PubMed Web of Science ®Google Scholar
• Komiyama K, Hirokawa Y, Morota T, Umezawa I. An acidic polysaccharide chlon A, from Chlorella pyrenoidosa. 2. Antitumor activity and immunological response. Chemotherapy 1986; 34: 302–307
   Google Scholar
• Yamaguchi N, Shimizu S, Murayama T, Wang R F, Tong Y C. Immunomodulation by single cellular algae [Chlorella pyrenoidosa] and anti-tumor activities for tumor-bearing mice. Proc Third Int Congress Dev Comp Immunol, July 7–13, Reims, France. 1985
   Google Scholar
• Russell I J, Vipraio G A, Morgan W W, Bowden C L. Is there a metabolic basis for the fibrositis syndrome?. Am J Med 1986; 81: 50–56
   PubMed Web of Science ®Google Scholar
• Burckhardt C S, Clark S R, Bennett R M. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991; 18: 728–733
   PubMed Web of Science ®Google Scholar
• DeLongis A, Folkman S, Lazarus R S. The impact of daily stress on health and mood: psychological and social resources a mediators. J Pers Soc Psychol 1988; 54: 486–495
   PubMed Web of Science ®Google Scholar
• Merchant R E, Rice C D, Young H F. Dietary Chlorella pyrenoidosa for patients with malignant brain tumor: Effects on immunocompetence, quality of life, and survival. Phytotherapy Res 1990; 4: 220–231
   Google Scholar
• Leal-Cerro A, Povedano J, Astorga R, Gonzalez M, Silva H, Garcia-Pesquera F, Casanueva F F, Dieguez C. The growth hormone [GH]-releasing hormone-GH-insu-lin-like growth factor-1 axis in patients with fibromyalgia syndrome. J Clin Endocrinol Metab 1999; 84: 3378–3381
   PubMed Web of Science ®Google Scholar
• Bennett R M, Clark S C, Walczyk J. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 1998; 104: 227–231
   PubMed Web of Science ®Google Scholar
• Bennett R M. Disordered growth hormone secretion in fibromyalgia: a review of recent findings and a hypothesized etiology. Z Rheumatol 57 Suppl 1998; 2: 72–76
   Google Scholar
• Buskila D. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 1999; 11: 119–126
   PubMedGoogle Scholar